MindWalk shares rise 10.29% premarket after advancing universal influenza program with breakthrough functional insight.

MindWalk Holdings Corp. (NASDAQ:HYFT) surged 10.29% in premarket trading following the announcement of a breakthrough in its universal influenza program. The company identified a conserved functional constraint across influenza A and B strains, including zoonotic subtypes, using its proprietary HYFT® Deep Data technology. This discovery, validated across human, avian, and swine influenza datasets, suggests a potential pathway for designing broadly protective vaccines by targeting biophysical constraints rather than genetic mutations. The news highlights the company’s Bio-Native AI platform’s ability to uncover durable therapeutic targets, aligning with its strategy to advance programs through out-licensing or partnerships. The announcement, coupled with heightened global influenza activity, underscores the clinical and commercial relevance of MindWalk’s platform, driving investor optimism.